| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |